Arteris, Inc. (NASDAQ:AIP) Sees Significant Decline in Short Interest

Arteris, Inc. (NASDAQ:AIP) saw a significant decrease in short interest during the month of January. As of January 30th, there was short interest totaling 1,134,548 shares, a decrease of 14.8% from the January 15th total of 1,331,050 shares. Based on an average trading volume of 453,470 shares, the short-interest ratio is presently 2.5 days. Currently, 3.9% of the company’s stock are sold short. Currently, 3.9% of the company’s stock are sold short. Based on an average trading volume of 453,470 shares, the short-interest ratio is presently 2.5 days.

Insider Buying and Selling at Arteris

In related news, major shareholder Bayview Legacy, Llc sold 2,756 shares of the business’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $15.03, for a total transaction of $41,422.68. Following the transaction, the insider directly owned 9,349,071 shares in the company, valued at $140,516,537.13. The trade was a 0.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO K Charles Janac sold 2,756 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $15.03, for a total value of $41,422.68. Following the transaction, the chief executive officer directly owned 9,349,071 shares in the company, valued at $140,516,537.13. This represents a 0.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 689,072 shares of company stock worth $11,525,611 over the last three months. Corporate insiders own 33.70% of the company’s stock.

Institutional Trading of Arteris

Several hedge funds and other institutional investors have recently bought and sold shares of AIP. Marshall Wace LLP raised its position in Arteris by 25.4% during the fourth quarter. Marshall Wace LLP now owns 209,782 shares of the company’s stock valued at $3,252,000 after acquiring an additional 42,492 shares in the last quarter. Bridgewater Associates LP grew its stake in shares of Arteris by 141.1% during the 4th quarter. Bridgewater Associates LP now owns 104,081 shares of the company’s stock worth $1,613,000 after purchasing an additional 60,912 shares during the period. Bank of Nova Scotia purchased a new position in shares of Arteris during the 4th quarter valued at approximately $194,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Arteris by 19.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 94,888 shares of the company’s stock valued at $1,471,000 after purchasing an additional 15,147 shares during the period. Finally, State Street Corp boosted its holdings in Arteris by 39.5% during the fourth quarter. State Street Corp now owns 760,113 shares of the company’s stock worth $11,782,000 after buying an additional 215,160 shares in the last quarter. 64.36% of the stock is owned by institutional investors and hedge funds.

Arteris Trading Down 2.0%

Shares of NASDAQ AIP opened at $14.62 on Monday. The company has a 50 day simple moving average of $16.23 and a two-hundred day simple moving average of $13.31. The stock has a market cap of $664.77 million, a price-to-earnings ratio of -17.83 and a beta of 1.48. Arteris has a 12 month low of $5.46 and a 12 month high of $19.85.

Arteris (NASDAQ:AIP) last released its quarterly earnings data on Thursday, February 12th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The business had revenue of $20.14 million during the quarter, compared to analyst estimates of $18.55 million. Analysts forecast that Arteris will post -0.73 EPS for the current year.

More Arteris News

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Q4 2025 results beat expectations: EPS of ($0.05) topped estimates and revenue of $20.14M beat consensus; management issued above‑consensus revenue guidance for Q1 and FY‑2026 — a clear fundamental positive supporting upside. Read More.
• Positive Sentiment: Commercial traction: Arteris reported its network‑on‑chip technology has shipped in over 4 billion devices, a credibility milestone that supports longer‑term revenue expansion in AI and edge markets. Read More.
• Positive Sentiment: Strategic moves: Management outlined a >$100M contract‑value target for 2026 and strengthened chip security capability via the Cycuity acquisition — both bolster the company’s addressable market and product offering. Read More.
• Positive Sentiment: Analyst/institutional support: Rosenblatt reaffirmed a Buy and $20 PT; several funds increased or initiated positions recently, which provides bench‑marked upside versus the current price.
• Neutral Sentiment: Earnings materials and call transcripts are available for deeper read‑throughs — these will be sources of further guidance detail and management color that could move shares. Read More.
• Neutral Sentiment: Short‑interest data in feeds is inconsistent (entries showing 0/NaN vs earlier reported short positions), so short‑squeeze risk is unclear until exchanges reconcile figures.
• Negative Sentiment: Large insider/major‑holder selling: CEO K. Charles Janac (and major holder Bayview Legacy, LLC) sold sizeable blocks in recent days (47,244 shares on Feb 9 plus additional sales), creating added supply and pressuring sentiment. Read More.
• Negative Sentiment: Mixed research view: some shops (Weiss) remain negative; consensus is a Hold with a $17.50 average target — divergent analyst views can increase short‑term volatility.

Analyst Ratings Changes

AIP has been the topic of a number of research analyst reports. TD Cowen restated a “buy” rating on shares of Arteris in a research note on Wednesday, November 5th. Jefferies Financial Group upgraded shares of Arteris to a “hold” rating in a research note on Tuesday, October 28th. Northland Securities set a $24.00 price target on shares of Arteris in a research note on Friday. Rosenblatt Securities reiterated a “buy” rating and set a $20.00 price objective on shares of Arteris in a research note on Friday. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, January 21st. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $20.17.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.